Hers vs Maximus: Which GLP-1 Provider Is Better?
Short answer: Hers scores higher on our rubric, 5.3/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.
Hers beats Maximus overall, scoring 5.3/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Maximus is published $79.99/mo; total not verified. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols.
A side-by-side look at Hers and Maximus to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#26 of 34The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersMaximus
#30 of 34Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit Maximus| Feature | Hers | Maximus |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market. |
| Our Score | 5.3/10 | 5.1/10 |
| Headline Price | $188 first month, then $298/mo | published $79.99/mo; total not verified |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | Men who want GLP-1 alongside testosterone or other men's health protocols |
| Watch out for | Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). | The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw |
| Ranking | #26 | #30 |
| Get started | Visit Hers | Visit Maximus |
Pros & Cons Compared
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Maximus
Pros
- +Advertised starting rate of $79.99/mo for compounded semaglutide, among the lowest headline prices we track; the same page also shows $150 per month, and lab work is billed separately
- +Compounded plans are flat rate across every dose, so titrating up does not reprice your plan
- +Maximus adds glycine and B12 to its compounded semaglutide, described on the site as a way to further customize and tailor the medication; it cites no clinical evidence for the combination
- +Free expedited shipping on all medication orders
Cons
- −The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
- −The fulfilling pharmacies are named only as initials in the help center, EVR, FCC or VIOS by state for compounded medication and The Pharmacy Hub for brand-name, and not on the product pages a shopper actually reads
- −Brand-name plans are priced by dose tier, so titrating up can move you to a higher monthly rate; compounded plans stay flat across all doses
- −FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding
Our Verdict
Hers edges out Maximus with a score of 5.3/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Maximus is published $79.99/mo; total not verified.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Hers and Maximus.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Hers and SkinnyRx$99 first month, rises after
- Compare Hers and Luvo Healthfrom $249/mo
- Compare Hers and Sesame Carepublished $99/mo; total not verified
- Compare Maximus and HealthRXfrom $99/mo
- Compare Maximus and Willow$299 first month, then $499/mo
- Compare Maximus and Ro$149/mo membership + medication
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit and is Maximus legit, with the verification evidence behind each answer.
Our pick of these two: Hers · 5.3/10